Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATIF Holdings Limited stock logo
ATIF
ATIF
$0.97
-0.4%
$0.98
$0.65
$2.00
$9.34M-0.4715,520 shs366 shs
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
$0.52
$0.38
$1.08
$52.18M0.81142,644 shs441,100 shs
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
$0.91
+2.2%
$2.15
$0.32
$2.66
$20.15M2.96218,447 shs110,932 shs
Information Services Group, Inc. stock logo
III
Information Services Group
$3.60
+0.3%
$4.07
$3.51
$5.87
$173.99M0.9594,155 shs36,914 shs
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$0.70
-12.5%
$0.87
$0.65
$1.10
$16.07M0.511,640 shs1,161 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATIF Holdings Limited stock logo
ATIF
ATIF
-1.65%+0.38%-10.67%+1.96%-45.60%
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
0.00%0.00%0.00%0.00%0.00%
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
+2.27%-3.73%-29.36%+243.85%-48.81%
Information Services Group, Inc. stock logo
III
Information Services Group
-0.28%-4.52%-11.14%-19.87%-28.63%
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
-12.50%-18.41%-12.50%-32.69%-32.04%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ATIF Holdings Limited stock logo
ATIF
ATIF
N/AN/AN/AN/AN/AN/AN/AN/A
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
N/AN/AN/AN/AN/AN/AN/AN/A
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
N/AN/AN/AN/AN/AN/AN/AN/A
Information Services Group, Inc. stock logo
III
Information Services Group
4.5401 of 5 stars
3.55.02.50.01.72.53.1
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATIF Holdings Limited stock logo
ATIF
ATIF
N/AN/AN/AN/A
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
N/AN/AN/AN/A
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
N/AN/AN/AN/A
Information Services Group, Inc. stock logo
III
Information Services Group
3.00
Buy$6.0066.67% Upside
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/AN/AN/AN/A

Current Analyst Ratings

Latest III, ATIF, AVCO, CIFS, and PBSV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/6/2024
Information Services Group, Inc. stock logo
III
Information Services Group
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$6.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATIF Holdings Limited stock logo
ATIF
ATIF
$2.45M3.81N/AN/A$0.16 per share6.06
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
$1.39M0.00N/AN/A$0.04 per share0.00
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
$14.40M1.40$0.40 per share2.27$2.95 per share0.31
Information Services Group, Inc. stock logo
III
Information Services Group
$291.05M0.60$0.40 per share9.09$2.09 per share1.72
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$16.98M0.95$0.06 per share12.22$0.70 per share1.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATIF Holdings Limited stock logo
ATIF
ATIF
-$2.88M-$0.47N/AN/A-1,153.75%-238.36%-105.66%6/12/2024 (Estimated)
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
-$9.09M-$0.09N/AN/AN/A-599.86%-444.65%-70.05%N/A
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
-$3.82MN/A0.00N/AN/AN/AN/AN/A
Information Services Group, Inc. stock logo
III
Information Services Group
$6.15M$0.1230.0010.000.992.12%12.89%5.50%5/9/2024 (Confirmed)
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$1.31M$0.0323.346.36N/A4.05%3.95%3.10%6/12/2024 (Estimated)

Latest III, ATIF, AVCO, CIFS, and PBSV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Information Services Group, Inc. stock logo
III
Information Services Group
$0.0620N/A-$0.0620N/AN/AN/A  
3/18/2024Q2 2024
ATIF Holdings Limited stock logo
ATIF
ATIF
N/A-$0.04-$0.04-$0.04N/A$0.03 million
3/18/2024Q1 2024
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$0.02-$0.01-$0.03-$0.01$5.00 million$2.38 million
3/7/2024Q4 2023
Information Services Group, Inc. stock logo
III
Information Services Group
$0.09$0.02-$0.07$0.10$69.16 million$66.19 million
1/29/2024Q4 2023
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
$0.03$0.03N/AN/A$5.00 million$3.60 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ATIF Holdings Limited stock logo
ATIF
ATIF
N/AN/AN/AN/AN/A
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
N/AN/AN/AN/AN/A
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
N/AN/AN/AN/AN/A
Information Services Group, Inc. stock logo
III
Information Services Group
$0.185.00%N/A150.00%1 Years
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/AN/AN/AN/AN/A

Latest III, ATIF, AVCO, CIFS, and PBSV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/5/2024
Information Services Group, Inc. stock logo
III
Information Services Group
Quarterly$0.04504.28%3/18/20243/19/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ATIF Holdings Limited stock logo
ATIF
ATIF
N/A
1.11
1.11
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
14.00
0.23
0.23
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
N/AN/AN/A
Information Services Group, Inc. stock logo
III
Information Services Group
0.78
2.44
2.44
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
N/A
5.10
5.10

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ATIF Holdings Limited stock logo
ATIF
ATIF
139.63 million4.31 millionNot Optionable
Avalon GloboCare Corp. stock logo
AVCO
Avalon GloboCare
699.22 million28.87 millionNot Optionable
China Internet Nationwide Fncl Srvcs Inc stock logo
CIFS
China Internet Nationwide Fncl Srvcs
16622.11 millionN/ANot Optionable
Information Services Group, Inc. stock logo
III
Information Services Group
1,51848.33 million40.60 millionNot Optionable
Pharma-Bio Serv, Inc. stock logo
PBSV
Pharma-Bio Serv
10022.96 million20.16 millionNot Optionable

III, ATIF, AVCO, CIFS, and PBSV Headlines

SourceHeadline
Biomarin Pharmaceutical earnings preview: what Wall Street is expectingBiomarin Pharmaceutical earnings preview: what Wall Street is expecting
markets.businessinsider.com - April 23 at 10:14 AM
Pharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below Two Hundred Day Moving Average of $0.92Pharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below Two Hundred Day Moving Average of $0.92
americanbankingnews.com - April 18 at 3:44 AM
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market ExpectationsBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectations
markets.businessinsider.com - April 16 at 3:38 AM
Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.coms Supplier Pre-assessment ProgramSanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com's Supplier Pre-assessment Program
tmcnet.com - April 9 at 8:56 AM
Looking Into Biomarin Pharmaceuticals Recent Short InterestLooking Into Biomarin Pharmaceutical's Recent Short Interest
benzinga.com - April 3 at 3:20 PM
PBSV Releases Quarterly ResultsPBSV Releases Quarterly Results
finance.yahoo.com - March 19 at 3:02 PM
Pharma-Bio Serv reports Q1 resultsPharma-Bio Serv reports Q1 results
seekingalpha.com - March 19 at 10:01 AM
Pharma-Bio Serv Announces Results for the Quarter…Pharma-Bio Serv Announces Results for the Quarter…
pharmiweb.com - March 19 at 12:00 AM
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
accesswire.com - March 18 at 5:10 PM
Buy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial OutlookBuy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial Outlook
markets.businessinsider.com - March 4 at 11:00 PM
Maintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market UncertaintiesMaintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market Uncertainties
markets.businessinsider.com - March 4 at 12:58 PM
BioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- UpdateBioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- Update
marketwatch.com - February 26 at 4:21 PM
Strong Voxzogo Performance Underpins Buy Rating for BioMarin PharmaceuticalStrong Voxzogo Performance Underpins Buy Rating for BioMarin Pharmaceutical
markets.businessinsider.com - February 23 at 8:53 PM
Pharma-Bio Serv reports revenue of $17M for 2023Pharma-Bio Serv reports revenue of $17M for 2023
newsismybusiness.com - January 31 at 7:39 AM
Regeneron Acquires 2seventy Bio Platforms and Preclinical & Clinical ProgramsRegeneron Acquires 2seventy Bio Platforms and Preclinical & Clinical Programs
contractpharma.com - January 30 at 4:38 PM
PBSV Expands Margins and MarketsPBSV Expands Margins and Markets
finance.yahoo.com - January 30 at 4:38 PM
Jubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger DealJubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger Deal
msn.com - January 28 at 10:10 AM
BridgeBio Pharma inks $1.25bnBridgeBio Pharma inks $1.25bn
pehub.com - January 23 at 12:11 PM
Optimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth DriversOptimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth Drivers
markets.businessinsider.com - January 9 at 8:52 PM
BridgeBio Pharmas Robust Pipeline Could Benefit From A PartnerBridgeBio Pharma's Robust Pipeline Could Benefit From A Partner
seekingalpha.com - January 8 at 8:02 AM
PBSV Reward Shareholders with High YieldPBSV Reward Shareholders with High Yield
finance.yahoo.com - January 3 at 3:22 PM
Pharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special DividendPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special Dividend
finanznachrichten.de - December 21 at 1:54 PM
AbbVies on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
msn.com - December 8 at 8:18 AM
BioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In GermanyBioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In Germany
markets.businessinsider.com - November 28 at 9:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

ATIF logo

ATIF

NASDAQ:ATIF
ATIF Holdings Limited operates as a business consulting company in Hong Kong, the United States, and Mexico. It offers financial consulting services to small and medium-sized enterprises (SMEs). The company primarily focuses on helping clients going public on the national stock exchanges and OTC markets in the United States. Its consulting services primarily include due diligence review, market research and feasibility study, business plan drafting, accounting record review, and business analysis and recommendations; reorganization, pre-listing education and tutoring, talent search, legal and audit firm recommendation and coordination, VIE contracts and other public-listing related documents review, merger and acquisition planning, investor referral and pre-listing equity financing source identification and recommendations, and independent directors and audit committee candidate's recommendation. The company also offers shell company identification and recommendation for customers expecting to become publicly listed through reverse merger transaction; assistance in preparation of customers' public filings for IPO or reverse merger transactions; and assistance in answering comments and questions received from regulatory agencies. In addition, it operates chinacnnm.com, a news and media website focuses on distributing financial news and information. ATIF Holdings Limited was incorporated in 2015 and is based in Lake Forest, California.
Avalon GloboCare logo

Avalon GloboCare

NASDAQ:AVCO
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.
China Internet Nationwide Fncl Srvcs logo

China Internet Nationwide Fncl Srvcs

NASDAQ:CIFS
China Internet Nationwide Financial Services Inc. provides financial advisory services to small-to-medium sized enterprises in the People's Republic of China. The company offers commercial payment advisory services, international corporate financing advisory services, intermediary bank loan advisory services, and Internet information services. China Internet Nationwide Financial Services Inc. was founded in 2014 and is based in Beijing, the People's Republic of China.
Information Services Group logo

Information Services Group

NASDAQ:III
Information Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; network carrier; technology strategy and operations design; change management; and market intelligence and technology research and analysis services. It supports private and public sector organizations to transform and optimize their operational environments. The company also provides ISG Digital, a client solution platform that helps clients developing technology, transformation, sourcing, and digital solutions; and ISG Enterprise, a client solution platform that helps clients manage change and optimize operations in areas comprising finance, human resource, and Procure2Pay. In addition, it offers ISG GovernX to automate the management of third-party supplier relationships that comprise contract and project lifecycles, and risk management; ISG Generative AI; ISG Network Select to streamline and simplify how enterprises build their network solutions; HR technology and transformations; providers-as-a-business services; ISG Digital Engineering; ISG Research; and training-as-a-service. The company serves private sector clients operating in the manufacturing, banking and financial services, insurance, health sciences, energy and utilities, and consumer services industries; and public sector clients, including state and local governments, airport and transit authorities, and national and provincial government units. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.
Pharma-Bio Serv logo

Pharma-Bio Serv

OTCMKTS:PBSV
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.